Algo version: 0.98b
Meribank Biotech Co Ltd is listed at the TWO Exchange
Meribank Biotech Co Ltd [4724.TWO]
TWO Sector: Healthcare Industry:Biotechnology

Is Meribank Biotech Co Ltd stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Meribank Biotech Co Ltd 10 years ago, but if you had invested on Friday 16th of June 2023 when the price was TWD31.00, you would have made a loss of TWD-0.700 per share or -2.26%

Yes, the average daily trading liquidity for Meribank Biotech Co Ltd is TWD105 756 thousand. You should therefore be able to get in and out of your positions relatively fast.

Meribank Biotech Co Ltd has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Meribank Biotech Co Ltd to be high [0.85 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.